Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis.

Lunney PC, Kariyawasam VC, Wang RR, Middleton KL, Huang T, Selinger CP, Andrews JM, Katelaris PH, Leong RW.

Aliment Pharmacol Ther. 2015 May 12. doi: 10.1111/apt.13239. [Epub ahead of print]

PMID:
25968332
2.

Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.

Kariyawasam VC, Selinger CP, Katelaris PH, Jones DB, McDonald C, Barr G, Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T, Andrews J, Leong RW.

Inflamm Bowel Dis. 2014 Aug;20(8):1382-90. doi: 10.1097/MIB.0000000000000119.

PMID:
24991785
3.

Education and Imaging. Gastrointestinal: Spigelian hernia; an uncommon cause of longstanding intermittent abdominal pain.

Mustaffa N, Leong RW, Katelaris PH.

J Gastroenterol Hepatol. 2013 Jan;28(1):202. doi: 10.1111/jgh.12027. No abstract available.

PMID:
23278154
4.

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy.

Adelstein BA, Macaskill P, Turner RM, Katelaris PH, Irwig L.

BMC Gastroenterol. 2011 Sep 8;11:97. doi: 10.1186/1471-230X-11-97.

5.

Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review.

Adelstein BA, Macaskill P, Chan SF, Katelaris PH, Irwig L.

BMC Gastroenterol. 2011 May 30;11:65. doi: 10.1186/1471-230X-11-65. Review.

6.

Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.

Park GJ, Wiseman E, George J, Katelaris PH, Seow F, Fung C, Ngu MC.

J Gastroenterol Hepatol. 2011 Sep;26(9):1411-6. doi: 10.1111/j.1440-1746.2011.06760.x.

PMID:
21557768
7.

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).

Scheiman JM, Devereaux PJ, Herlitz J, Katelaris PH, Lanas A, Veldhuyzen van Zanten S, Nauclér E, Svedberg LE.

Heart. 2011 May;97(10):797-802. doi: 10.1136/hrt.2010.217547. Epub 2011 Mar 17.

8.

An objective study of acid reflux and cough in children using an ambulatory pHmetry-cough logger.

Chang AB, Connor FL, Petsky HL, Eastburn MM, Lewindon PJ, Hall C, Wilson SJ, Katelaris PH.

Arch Dis Child. 2011 May;96(5):468-72. doi: 10.1136/adc.2009.177733. Epub 2010 Jun 1.

PMID:
20515960
9.

Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history.

Adelstein BA, Irwig L, Macaskill P, Turner RM, Chan SF, Katelaris PH.

Aliment Pharmacol Ther. 2010 Jul;32(2):270-81. doi: 10.1111/j.1365-2036.2010.04344.x. Epub 2010 May 3.

PMID:
20456307
10.

Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.

Haag S, Andrews JM, Katelaris PH, Gapasin J, Galmiche JP, Hunt R, Layer P, Malfertheiner P, Holtmann G.

Digestion. 2009;80(4):226-34. doi: 10.1159/000235953. Epub 2009 Oct 16. Review.

11.

Helicobacter pylori: antibiotic resistance and treatment options.

Katelaris PH.

J Gastroenterol Hepatol. 2009 Jul;24(7):1155-7. doi: 10.1111/j.1440-1746.2009.05911.x. No abstract available.

PMID:
19682186
12.

Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.

Eggleston A, Katelaris PH, Nandurkar S, Thorpe P, Holtmann G; Treat Study Group.

Aliment Pharmacol Ther. 2009 May 1;29(9):967-78. doi: 10.1111/j.1365-2036.2009.03948.x. Epub 2009 Feb 3.

PMID:
19210493
13.

A self administered reliable questionnaire to assess lower bowel symptoms.

Adelstein BA, Irwig L, Macaskill P, Katelaris PH, Jones DB, Bokey L.

BMC Gastroenterol. 2008 Mar 1;8:8. doi: 10.1186/1471-230X-8-8.

14.

The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.

Van der Poorten D, Katelaris PH.

Aliment Pharmacol Ther. 2007 Dec;26(11-12):1537-42. Epub 2007 Sep 28.

15.

Whistler summary: "the slow rate of rapid progress".

Hunt RH, Tytgat GH, Malfertheiner P, Fock KM, Heading RC, Katelaris PH, McCarthy DM, McColl KE, Moss SF, Sachs G, Sontag SJ, Thomson AB, Modlin IM.

J Clin Gastroenterol. 2007 Jul;41(6):539-45. No abstract available.

PMID:
17577108
16.
17.

Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn's disease.

Chan RC, Katelaris PH, Stewart P, Lin BP.

Hum Pathol. 2006 May;37(5):631-4. Epub 2006 Mar 13.

PMID:
16647963
18.

Gastro-oesophageal reflux disease and Helicobacter pylori.

Katelaris PH.

Minerva Gastroenterol Dietol. 2003 Dec;49(4):235-41.

PMID:
16484964
19.

The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy.

Park GJ, Katelaris PH, Jones DB, Seow F, Lin BP, Le Couteur DG, Ngu MC.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):395-403.

20.

An evaluation of current GERD therapy: a summary and comparison of effectiveness, adverse effects and costs of drugs, surgery and endoscopic therapy.

Katelaris PH.

Best Pract Res Clin Gastroenterol. 2004;18 Suppl:39-45. Review. No abstract available.

PMID:
15588794
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk